Submitted by Anonymous (not verified) on 13 August 2026 - 13:20
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 3, Status: Authorised